
Cells, Год журнала: 2024, Номер 13(22), С. 1918 - 1918
Опубликована: Ноя. 19, 2024
Breast cancer is a heterogeneous disease comprising multiple molecularly distinct subtypes with varied prevalence, prognostics, and treatment strategies. Among them, triple-negative breast cancer, though the least prevalent, most aggressive subtype, limited therapeutic options. Recent emergence of competing endogenous RNA (ceRNA) networks has highlighted how long noncoding RNAs (lncRNAs), microRNAs (miRs), mRNA orchestrate complex interplay meticulously modulating functionality. Focusing on TNBC, this study aimed to construct ceRNA network using differentially expressed lncRNAs, miRs, mRNAs. We queried lncRNAs (DElncRNAs) between TNBC luminal samples found 389 upregulated 386 downregulated including novel transcripts in TNBC. DElncRNAs were further evaluated for their clinical, functional, mechanistic relevance TNBCs lnc2cancer 3.0 database, which presented LUCAT1 (lung cancer-associated transcript 1) as putative node. Next, (lncRNA-miRNA-mRNA) was established. Several miRNA-mRNA connections implicated regulating stemness (LUCAT1-miR-375-Yap1, LUCAT1-miR181-5p-Wnt, LUCAT1-miR-199a-5p-ZEB1), apoptosis (LUCAT1-miR-181c-5p-Bcl2), drug efflux (LUCAT1-miR-200c-ABCB1, LRP1, MRP5, MDR1), sheddase activities (LUCAT1-miR-493-5p-ADAM10) identified, indicating an intricate regulatory mechanism Indeed, silencing led mitigated cell growth, migration, stem-like features This work sheds light implies its involvement growth progression.
Язык: Английский